Study Shows Rates of Lung Cancer Higher in Women Than Men
A new study examines why females have higher chances of developing lung cancer than males. Lung cancer rates were the highest among male smokers in the last few decades. Nevertheless, women have been more likely to suffer from this type of cancer over the previous years, despite being non-smokers.
The increased cancer risk for women may be due to several factors, such as smoke inhaled from tobacco being smoked by others, breathing in radon for a longer time, or cooking indoors. Even though female patients have better results from lung cancer treatments than those who are male, researchers want to investigate the possible factors responsible for the higher rates in women.
The research team analyzed screening and diagnosis patterns and results of lung cancer patients. As a result, they discovered some distinctions between male and female patients, particularly the development of the disease, the results from the therapy, and the adverse reactions from the treatment.
Even though lung cancer rates among non-smokers are increased, most patients are smokers or were using tobacco in the past. As reported by EPA, radon, a radioactive chemical element found in soil, rock, and water, is the leading cause of this type of cancer in people who do not smoke. The second most prevalent reason for lung cancer is the use of tobacco.
Among the other causes of lung cancer is indoor cooking fumes, and women who prepare food using coal have higher chances of developing it. In addition, cooking oils can cause the formation of carcinogens. Moreover, cooking in rooms that are not adequately ventilated increases the exposure to carcinogens, thus the likelihood of developing lung cancer.
The present guidelines across the world for lung cancer screening demand presenting the history of tobacco use. In line with that, the increased lung cancer rates in non-smokers are not included in the guidelines. For this reason, researchers believe that the guidelines should include tobacco use and other risk factors. Moreover, clinical trials should also examine the gender-based distinctions in people with lung cancer.
Photo by Thirdman on Pexels